(Q40708111)

22 September 2017

1 reference

title

Antihypertensive therapy in the geriatric patient: II. A review of the alpha1-adrenergic blocking agents (English)

1 reference

22 September 2017

Studer JA

1

1 reference

PubMed ID

8094084

22 September 2017

Piepho RW

series ordinal

2

1 reference

22 September 2017

1 January 1993

1 reference

The Journal of Clinical Pharmacology

22 September 2017

1 reference

22 September 2017

33

1 reference

22 September 2017

2-13

1 reference

22 September 2017

1

1 reference

Antihypertensive therapy in the geriatric patient. I: A review of the role of calcium channel blockers

22 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Hypertension in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

The balance between vascular alpha- and beta-adrenoceptors is not changed in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Osler's maneuver, pseudohypertension, and true hypertension in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Pharmacokinetic changes in aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

New insights and new approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

New alpha 1-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Prazosin Update A Review of its Pharmacological Properties and Therapeutic Use in Hypertension and Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Mild hypertension in the elderly. A comparison of prazosin and enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Prazosin disposition in young and elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Clinical pharmacokinetics of prazosin--1985.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Clinical pharmacological studies with doxazosin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

The pharmacokinetics of doxazosin in elderly normotensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Pharmacologic profile of urapidil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Urapidil, a multiple-action alpha-blocking drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Prazosin in the treatment of chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Effect of terazosin on serum lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1993.TB03896.X

10.1002/J.1552-4604.1993.TB03896.X

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

8094084